These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 23986578)
1. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation. Bottero V; Sadagopan S; Johnson KE; Dutta S; Veettil MV; Chandran B J Virol; 2013 Nov; 87(21):11806-20. PubMed ID: 23986578 [TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle. Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106 [TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions. Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557 [TBL] [Abstract][Full Text] [Related]
4. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications. Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ mBio; 2018 May; 9(3):. PubMed ID: 29739902 [TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells. Paudel N; Sadagopan S; Balasubramanian S; Chandran B J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534 [TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. Sadagopan S; Sharma-Walia N; Veettil MV; Bottero V; Levine R; Vart RJ; Chandran B J Virol; 2009 Apr; 83(7):3342-64. PubMed ID: 19158252 [TBL] [Abstract][Full Text] [Related]
7. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus. Zhang YJ; Patel D; Nan Y; Fan S Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187 [TBL] [Abstract][Full Text] [Related]
10. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells. Long C; Guo W; Zhou H; Wang J; Wang H; Sun X Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279 [TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7. Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866 [TBL] [Abstract][Full Text] [Related]
12. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells. Smith CG; Kharkwal H; Wilson DW J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496 [TBL] [Abstract][Full Text] [Related]
13. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection. Katano H Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675 [TBL] [Abstract][Full Text] [Related]
14. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection. Fukumoto H; Kanno T; Hasegawa H; Katano H Front Microbiol; 2011; 2():175. PubMed ID: 21904536 [TBL] [Abstract][Full Text] [Related]
15. LKB1 suppresses KSHV reactivation and promotes primary effusion lymphoma progression. Li G; Li Y; Tang X; Wang L; Yue S; He S; Li T J Virol; 2024 Sep; 98(9):e0060424. PubMed ID: 39194241 [TBL] [Abstract][Full Text] [Related]
16. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication. Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712 [TBL] [Abstract][Full Text] [Related]
17. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research]. Watanabe T; Fujimuro M Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932 [TBL] [Abstract][Full Text] [Related]
18. A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin. Kadota A; Moriguchi M; Watanabe T; Sekine Y; Nakamura S; Yasuno T; Ohe T; Mashino T; Fujimuro M Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014678 [TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL). Dai L; Trillo-Tinoco J; Bai L; Kang B; Xu Z; Wen X; Del Valle L; Qin Z PLoS One; 2014; 9(2):e90349. PubMed ID: 24587336 [TBL] [Abstract][Full Text] [Related]
20. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma. Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]